At a glance
ClinicalIndex Comparison RecordN/AUnknown· 258 target
Drug / intervention
high flow nasal cannula +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients
In Brief
A clinical study evaluating high flow nasal cannula and nasal prong for Pediatric Sedation. Targeting 258 participants across 1 site.
Detailed Summary
The investigators evaluate the efficacy and safety of routine administration of oxygen during moderate or deep sedation in pediatric patients. In addition, in terms of efficacy and safety, oxygen administration via nasal prong and high flow nasal cannula will be compared.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPediatric Sedation
CountriesSouth Korea
Collaborators--
Timeline
N/AUnknownOverdue
20222023202420252026
First PostedApr 2021
Enrollment StartJul 2021
Primary CompletionApr 2024
Study CompletionDec 2024
TodayJul 2026
First PostedApr 21, 2021
Enrollment StartJul 27, 2021
Primary CompletionApr 30, 2024
Study CompletionDec 30, 2024
TodayJul 1, 2026
Enrollment to primary: 2.8 yearsPosted 5.2 years ago
Interventions
high flow nasal cannuladevice
The heated air is administered at a rate of 2L/kg/min using an Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand). Inhalation oxygen concentration starts with 50%.
nasal prongdevice
Oxygen is administered via nasal prong